Loading...
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?
The objective of this study was to assess the achievement of pharmacokinetic/pharmacodynamic (PK/PD) targets of meropenem (MEM) in critically-ill patients with bloodstream infections (BSI) due to Klebsiella pneumoniae-carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) with MEM minimum inhibitory...
Na minha lista:
| Udgivet i: | Virulence |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5963200/ https://ncbi.nlm.nih.gov/pubmed/27430122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21505594.2016.1213476 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|